Loading…
Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus
OBJECTIVE: The roles of cyclins and cyclin dependent kinase (CDK) inhibitors of lymphocytes in the pathogenesis of systemic lupus erythematosus (SLE) are unclear. We measured the expression of cyclin B1 and CDK inhibitor p21 in peripheral blood lymphocytes (PBL) from patients with SLE and controls....
Saved in:
Published in: | Journal of rheumatology 2002-12, Vol.29 (12), p.2537-2544 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | OBJECTIVE: The roles of cyclins and cyclin dependent kinase (CDK) inhibitors of lymphocytes in the pathogenesis of systemic
lupus erythematosus (SLE) are unclear. We measured the expression of cyclin B1 and CDK inhibitor p21 in peripheral blood lymphocytes
(PBL) from patients with SLE and controls. METHODS: PBL from 40 SLE patients with renal disease (RSLE), 40 SLE patients without
renal disease (SLE), and 28 healthy control subjects were cultured with phytohemagglutinin (PHA). Bivariate distribution of
cyclin B1 or p21 expression versus cellular DNA content was assessed by flow cytometry. RESULTS: Expression of p21 in lymphocytes
was significantly lower in patients with RSLE and with SLE than controls (RSLE vs controls and SLE vs controls, both p < 0.001).
Expression of cyclin B1 was similar in all groups. The percentages of RSLE lymphocytes in G0/G1 and S phase were significantly
reduced and elevated, respectively, compared with controls. CONCLUSION: Downregulated p21 in PHA stimulated PBL from patients
with SLE may be closely related to aberration of cell division in SLE lymphocytes. |
---|---|
ISSN: | 0315-162X 1499-2752 |